Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.75 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.67 |
| ▸ | MEN1 | O00255 | 3/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.60 |
| ▸ | MAPT | P10636 | 2/20 | 0.60 |
| ▸ | THRB | P10828 | 1/20 | 0.60 |
| ▸ | HTT | P42858 | 1/20 | 0.60 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.57 |
| ▸ | MGLL | Q99685 | 1/20 | 0.54 |
| ▸ | PAM | P19021 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.50 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.50 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7997281 | 1.00 | DGKA (0.75) | DGKAEPHX2MEN1KMT2AMAPT | |
| SCHEMBL65429 | 1.00 | DGKA (0.75) | DGKAEPHX2MEN1KMT2AMAPT | |
| SCHEMBL9416192 | 1.00 | DGKA (0.75) | DGKAEPHX2MEN1KMT2AMAPT | |
| SCHEMBL13293981 | 1.00 | DGKA (0.75) | DGKAEPHX2MEN1KMT2AMAPT | |
| SCHEMBL9551685 | 1.00 | DGKA (0.75) | DGKAEPHX2MEN1KMT2AMAPT | |
| SCHEMBL9230589 | 1.00 | DGKA (0.75) | DGKAEPHX2MEN1KMT2AMAPT | |
| SCHEMBL42804 | 1.00 | DGKA (0.75) | DGKAEPHX2MEN1KMT2AMAPT | |
| SCHEMBL5145922 | 1.00 | DGKA (0.75) | DGKAEPHX2MEN1KMT2AMAPT | |
| SCHEMBL9224706 | 1.00 | DGKA (0.75) | DGKAEPHX2MEN1KMT2AMAPT | |
| SCHEMBL19064546 | 1.00 | DGKA (0.75) | DGKAEPHX2MEN1KMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118237377-A | Harmful chemical substance removing processing technology for packaging bag raw materials | 湖北金德包装有限公司 | 2024-06-25 | — | — | CN | claimed |
| CN-116463874-A | Waste paper surface ink fiber separation process | 江苏理文造纸有限公司 | 2023-07-21 | — | — | CN | claimed |
| CN-114042067-A | Amoxicillin sodium for injection and preparation method thereof | 江西利德菲生物药业有限公司 | 2022-02-15 | — | — | CN | claimed |
| EP-2792350-B1 | NANOPARTICULATE SYSTEMS PREPARED FROM SORBITAN ESTERS | UNIV SANTIAGO COMPOSTELA (ES) | 2020-12-30 | — | — | EP | claimed |
| US-9861588-B2 | Nanoparticulate systems prepared from sorbitan esters | UNIVERSIDADE DE SANTIAGO DE COMPOSTELA (ES) | 2018-01-09 | — | — | US | claimed |
| US-20140314852-A1 | NANOPARTICULATE SYSTEMS PREPARED FROM SORBITAN ESTERS | UNIVERSIDADE DE SANTIAGO DE COMPOSTELA (ES) | 2014-10-23 | — | — | US | claimed |
| EP-2792350-A1 | NANOPARTICULATE SYSTEMS PREPARED FROM SORBITAN ESTERS | Universidade De Santiago De Compostela (ES) | 2014-10-22 | — | — | EP | claimed |
| US-20050169877-A1 | Process for preparing a composition using pressurized fluid, composition prepared, and uses thereof | L'OREAL (FR) | 2005-08-04 | — | — | US | claimed |
| US-20250084249-A1 | Polyacetal Resin Composition | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2025-03-13 | — | — | US | disclosed |
| EP-4467609-A1 | POLYACETAL RESIN COMPOSITION | Asahi Kasei Kabushiki Kaisha (JP) | 2024-11-27 | — | — | EP | disclosed |
| US-20240328481-A1 | Cellulose-containing Gear | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2024-10-03 | — | — | US | disclosed |
| CN-118556106-A | Polyacetal resin composition | 旭化成株式会社 | 2024-08-27 | — | — | CN | disclosed |
| US-20240209068-A1 | MUCOSAL EXPRESSION OF ANTIBODY STRUCTURES AND ISOTYPES BY MRNA | MODERNATX, INC. (US) | 2024-06-27 | — | — | US | disclosed |
| CN-118237377-A | Harmful chemical substance removing processing technology for packaging bag raw materials | 湖北金德包装有限公司 | 2024-06-25 | — | — | CN | disclosed |
| US-5063119-A | Magnetic recording medium comprising a fluorine containing oligomer surfactant in or on the magnetic layer | FUJI PHOTO FILM CO., LTD. (JP) | 1991-11-05 | — | — | US | disclosed |
| US-4876094-A | DUAL COATED CORES IN ACIDIC CARRIER LIQUID; SHELF LIFE | BATTELLE DEVELOPMENT CORPORATION (US) | 1989-10-24 | — | — | US | disclosed |
| US-4751118-A | CONTAINING AN ETHER STABILIZER | THE B. F. GOODRICH COMPANY (US) | 1988-06-14 | — | — | US | disclosed |
| EP-0212648-A2 | Clear polyvinyl chloride articles and compositions | The B.F. GOODRICH Company (US) | 1987-03-04 | — | — | EP | disclosed |
| US-4175979-A | MIXING AN AQUEOUS PROTECTIVE COLLOID, WATER INSOLUBLE CARRIER, AN AQUEOUS DISPERSION OF PIGMENT OR WATER INSOLUBLE DYESTUFF AND SEPARATING | CIBA-GEIGY CORPORATION (US) | 1979-11-27 | — | — | US | disclosed |
| US-3975350-A | HYDROPHILIC OR HYDROGEL CARRIER SYSTEMS SUCH AS COATINGS, BODY IMPLANTS AND TOHER ARTICLES | PRINCETON POLYMER LABORATORIES, INCORPORATED (US) | 1976-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240209068-A1 | MUCOSAL EXPRESSION OF ANTIBODY STRUCTURES AND ISOTYPES BY MRNA | NSUN3, IGLV6-57, MRPS23 | DGKA 803/4885EPHX2 4522/4885MEN1 2764/4885 |
| US-20050169877-A1 | Process for preparing a composition using pressurized fluid, composition prepared, and uses thereof | KRT18, KRTCAP2, CKAP4 | DGKA 1509/4885EPHX2 3703/4885MEN1 1700/4885 |
| US-20140314852-A1 | NANOPARTICULATE SYSTEMS PREPARED FROM SORBITAN ESTERS | MLEC, LAGE3, SORBS1 | DGKA 823/4885EPHX2 431/4885MEN1 416/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.